NCT06505837 2025-08-28
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）
Shanghai Junshi Bioscience Co., Ltd.
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT05894889 2025-07-23
Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC
Peking University
Phase 2 Active not recruiting
NCT05798533 2023-07-10
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
BGI, China
Phase 1 Unknown
NCT05798546 2023-04-04
Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)
BGI, China
Phase 1 Unknown